These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 448075

  • 1. Activation of the classical pathway of complement by the C3NeF-stabilized cell-bound amplification convertase.
    Daha MR, van Es LA.
    J Immunol; 1979 Mar; 122(3):801-5. PubMed ID: 448075
    [Abstract] [Full Text] [Related]

  • 2. Activation of the classical complement pathway by nephritic factor bound to the alternative pathway C3/C5 convertase.
    Sobel AT, Cooper NR, Schreiber RD.
    J Immunol; 1979 Jan; 122(1):34-8. PubMed ID: 762421
    [Abstract] [Full Text] [Related]

  • 3. Further evidence for the antibody nature of C3 nephritic factor (C3NeF).
    Daha MR, van Es LA.
    J Immunol; 1979 Aug; 123(2):755-8. PubMed ID: 379217
    [Abstract] [Full Text] [Related]

  • 4. Protection of the classical and alternative complement pathway C3 convertases, stabilized by nephritic factors, from decay by the human C3b receptor.
    Fischer E, Kazatchkine MD, Mecarelli-Halbwachs L.
    Eur J Immunol; 1984 Dec; 14(12):1111-4. PubMed ID: 6240408
    [Abstract] [Full Text] [Related]

  • 5. C3 nephritic factor (C3NeF): dissociation of cell-bound and fluid phase stabilization of alternative pathway C3 convertase.
    Ng YC, Peters DK.
    Clin Exp Immunol; 1986 Aug; 65(2):450-7. PubMed ID: 3641695
    [Abstract] [Full Text] [Related]

  • 6. Production of nephritic factor of the alternative complement pathway by Epstein Barr virus-transformed B cell lines derived from a patient with membranoproliferative glomerulonephritis.
    Hiramatsu M, Balow JE, Tsokos GC.
    J Immunol; 1986 Jun 15; 136(12):4451-5. PubMed ID: 3011894
    [Abstract] [Full Text] [Related]

  • 7. Pathways of complement activation in membranoproliferative glomerulonephritis and allograft rejection.
    Fearon DT, Daha MR, Strom TB, Weiler JM, Carpenter CB, Austen KF.
    Transplant Proc; 1977 Mar 15; 9(1):729-39. PubMed ID: 325806
    [Abstract] [Full Text] [Related]

  • 8. Effect of decay-accelerating factor on the assembly of the classical and alternative pathway C3 convertases in the presence of C4 or C3 nephritic factor.
    Ito S, Tamura N, Fujita T.
    Immunology; 1989 Dec 15; 68(4):449-52. PubMed ID: 2481642
    [Abstract] [Full Text] [Related]

  • 9. Complement activation by heat-killed human kidney cells: formation, activity, and stabilization of cell-bound C3 convertases.
    Baker PJ, Adler S, Yang Y, Couser WG.
    J Immunol; 1984 Aug 15; 133(2):877-81. PubMed ID: 6376629
    [Abstract] [Full Text] [Related]

  • 10. Surface modulation of classical pathway activation: C2 and C3 convertase formation and regulation on sheep, guinea pig, and human erythrocytes.
    Brown EJ, Ramsey J, Hammer CH, Frank MM.
    J Immunol; 1983 Jul 15; 131(1):403-8. PubMed ID: 6602833
    [Abstract] [Full Text] [Related]

  • 11. Relative resistance of the F-42-stabilized classical pathway C3 convertase to inactivation by C4-binding protein.
    Daha MR, van Es LA.
    J Immunol; 1980 Nov 15; 125(5):2051-4. PubMed ID: 6903579
    [Abstract] [Full Text] [Related]

  • 12. C3 nephritic factor (C3NeF): stabilization of fluid phase and cell-bound alternative pathway convertase.
    Daha MR, Fearon DT, Austen KF.
    J Immunol; 1976 Jan 15; 116(1):1-7. PubMed ID: 1245733
    [Abstract] [Full Text] [Related]

  • 13. Regulation and deregulation of the fluid-phase classical pathway C3 convertase.
    Gigli I, Sorvillo J, Halbwachs-Mecarelli L.
    J Immunol; 1985 Jul 15; 135(1):440-4. PubMed ID: 3158705
    [Abstract] [Full Text] [Related]

  • 14. Stabilization of homologous and heterologous cell-bound amplification convertases, C3bBb, by C3 nephritic factor.
    Daha MR, Van Es LA.
    Immunology; 1981 May 15; 43(1):33-8. PubMed ID: 6166544
    [Abstract] [Full Text] [Related]

  • 15. Stabilization of the amplification convertase of complement by monoclonal antibodies directed against human factor B.
    Daha MR, Deelder AM, Van Es LA.
    J Immunol; 1984 May 15; 132(5):2538-42. PubMed ID: 6232321
    [Abstract] [Full Text] [Related]

  • 16. Biological significance of the C3 nephritic factor in membranoproliferative glomerulonephritis.
    Schena FP, Pertosa G, Stanziale P, Vox E, Pecoraro C, Andreucci VE.
    Clin Nephrol; 1982 Nov 15; 18(5):240-6. PubMed ID: 7151338
    [Abstract] [Full Text] [Related]

  • 17. Regulation of the C3 nephritic factor stabilized C3/C5 convertase of complement by purified human erythrocyte C3b receptor.
    Daha MR, Kok DJ, Van Es LA.
    Clin Exp Immunol; 1982 Oct 15; 50(1):209-14. PubMed ID: 6216999
    [Abstract] [Full Text] [Related]

  • 18. Heterogeneity, polypeptide chain composition and antigenic reactivity of autoantibodies (F-42) that are directed against the classical pathway C3 convertase of complement and isolated from sera of patients with systemic lupus erythematosus.
    Daha MR, Hazevoet HM, van Es LA.
    Clin Exp Immunol; 1984 Jun 15; 56(3):614-20. PubMed ID: 6430610
    [Abstract] [Full Text] [Related]

  • 19. Mechanism of activation of the classical pathway of complement by monoclonal IgE (DES). Restricted regulation of C4b by C4b-binding protein.
    Saint-Remy JM.
    Eur J Immunol; 1984 Mar 15; 14(3):254-9. PubMed ID: 6608450
    [Abstract] [Full Text] [Related]

  • 20. Eosinophil granule major basic protein regulates generation of classical and alternative-amplification pathway C3 convertases in vitro.
    Weiler JM, Gleich GJ.
    J Immunol; 1988 Mar 01; 140(5):1605-10. PubMed ID: 3346544
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.